These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 12136061

  • 21. Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET study.
    Samuel M, Ceballos-Baumann AO, Turjanski N, Boecker H, Gorospe A, Linazasoro G, Holmes AP, DeLong MR, Vitek JL, Thomas DG, Quinn NP, Obeso JA, Brooks DJ.
    Brain; 1997 Aug; 120 ( Pt 8)():1301-13. PubMed ID: 9278624
    [Abstract] [Full Text] [Related]

  • 22. Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson's Disease.
    Mueller K, Jech R, Ballarini T, Holiga Š, Růžička F, Piecha FA, Möller HE, Vymazal J, Růžička E, Schroeter ML.
    Cerebellum; 2019 Apr; 18(2):212-224. PubMed ID: 30298443
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
    Palmer SJ, Eigenraam L, Hoque T, McCaig RG, Troiano A, McKeown MJ.
    Neuroscience; 2009 Jan 23; 158(2):693-704. PubMed ID: 18722512
    [Abstract] [Full Text] [Related]

  • 26. Local cerebral blood flow and its response to intravenous levodopa in progressive supranuclear palsy. Comparison with Parkinson's disease.
    Kobari M, Fukuuchi Y, Shinohara T, Nogawa S, Takahashi K.
    Arch Neurol; 1992 Jul 23; 49(7):725-30. PubMed ID: 1497499
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Neuroprotective Effects of Rasagiline in Parkinson's Disease: A Regional Cerebral Blood Flow Study.
    Im JJ, Jeong H, Chung YA, Park JS, Heo Y, Oh JK, Song IU.
    J Neuroimaging; 2019 Nov 23; 29(6):707-711. PubMed ID: 31463990
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Levodopa-induced striatal activation in Parkinson's disease: a functional MRI study.
    Kraft E, Loichinger W, Diepers M, Lule D, Schwarz J, Ludolph AC, Storch A.
    Parkinsonism Relat Disord; 2009 Sep 23; 15(8):558-63. PubMed ID: 19467909
    [Abstract] [Full Text] [Related]

  • 33. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
    Hohlefeld FU, Huchzermeyer C, Huebl J, Schneider GH, Nolte G, Brücke C, Schönecker T, Kühn AA, Curio G, Nikulin VV.
    Neuroscience; 2013 Oct 10; 250():320-32. PubMed ID: 23876322
    [Abstract] [Full Text] [Related]

  • 34. Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.
    Stocchi F, Rabey JM.
    Eur J Neurol; 2011 Dec 10; 18(12):1373-8. PubMed ID: 21895884
    [Abstract] [Full Text] [Related]

  • 35. Levodopa pharmacokinetic-pharmacodynamic modeling and 6-[18F]levodopa positron emission tomography in patients with Parkinson's disease.
    Dietz M, Harder S, Graff J, Künig G, Vontobel P, Leenders KL, Baas H.
    Clin Pharmacol Ther; 2001 Jul 10; 70(1):33-41. PubMed ID: 11452242
    [Abstract] [Full Text] [Related]

  • 36. Network modulation in the treatment of Parkinson's disease.
    Asanuma K, Tang C, Ma Y, Dhawan V, Mattis P, Edwards C, Kaplitt MG, Feigin A, Eidelberg D.
    Brain; 2006 Oct 10; 129(Pt 10):2667-78. PubMed ID: 16844713
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects.
    Jahanshahi M, Jenkins IH, Brown RG, Marsden CD, Passingham RE, Brooks DJ.
    Brain; 1995 Aug 10; 118 ( Pt 4)():913-33. PubMed ID: 7655888
    [Abstract] [Full Text] [Related]

  • 39. Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes.
    Antonini A, Yegin A, Preda C, Bergmann L, Poewe W, GLORIA study investigators and coordinators.
    Parkinsonism Relat Disord; 2015 Mar 10; 21(3):231-5. PubMed ID: 25585993
    [Abstract] [Full Text] [Related]

  • 40. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism.
    Fukuda M, Mentis MJ, Ma Y, Dhawan V, Antonini A, Lang AE, Lozano AM, Hammerstad J, Lyons K, Koller WC, Moeller JR, Eidelberg D.
    Brain; 2001 Aug 10; 124(Pt 8):1601-9. PubMed ID: 11459751
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.